Sutro Biopharma (STRO) Total Current Liabilities (2017 - 2026)
Sutro Biopharma's Total Current Liabilities came in at $52.9 million for Q2 2026, down 28.8% from $74.25 million a year earlier.
Powered by 
Analysis
Sutro Biopharma (STRO) Total Current Liabilities (2017 - 2026) Analysis & Trends
At the end of FY2025, Sutro Biopharma's Total Current Liabilities was $75.13 million, down 43.0% from FY2024.
- Total Current Liabilities carries a five-year compound annual growth rate of 20.5% (FY2020 to FY2025).
- Going back by year, Total Current Liabilities was $131.89 million in FY2024 (+40.7%), $93.75 million in FY2023 (+40.9%), $66.55 million in FY2022 (+59.4%) and $41.74 million in FY2021 (+41.0%).
- The Q2 2026 figure represents the lowest quarterly Total Current Liabilities since Q2 2022.
- Year-over-year, Total Current Liabilities increased in three of the last seven quarters, with growth averaging 3.8%.
- The fastest year-over-year change in Total Current Liabilities over five years came in Q2 2024 (growth of 93.6%), and the weakest in Q3 2025 (a decline of 45.2%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 54.90 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 41.64 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 27.73 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 31.75 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | -31.55 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 25.50 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 11.02 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 32.65 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 3.94 Bn |
| 10 | Sutro Biopharma | 265.72 Mn | -412.78 Mn | - | 52.90 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 52.90 Mn |
| Dec 31, 2025 | 75.13 Mn |
| Sep 30, 2025 | 71.90 Mn |
| Jun 30, 2025 | 74.25 Mn |
| Mar 31, 2025 | 133.05 Mn |
| Dec 31, 2024 | 131.89 Mn |
| Sep 30, 2024 | 131.29 Mn |
| Jun 30, 2024 | 129.99 Mn |
| Mar 31, 2024 | 79.51 Mn |
| Dec 31, 2023 | 93.75 Mn |
| Sep 30, 2023 | 73.61 Mn |
| Jun 30, 2023 | 67.13 Mn |
| Mar 31, 2023 | 59.49 Mn |
| Dec 31, 2022 | 66.55 Mn |
| Sep 30, 2022 | 58.29 Mn |
| Jun 30, 2022 | 44.57 Mn |
| Mar 31, 2022 | 38.76 Mn |
| Dec 31, 2021 | 41.74 Mn |
| Sep 30, 2021 | 35.46 Mn |
| Jun 30, 2021 | 26.13 Mn |
API Access
Sutro Biopharma Total Current Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=total-current-liabilities&ticker=STRO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "total-current-liabilities", "ticker": "STRO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=total-current-liabilities&ticker=STRO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();